喉罩在心血管内科介入手术麻醉中的应用效果探讨

摘要

目的：分析在心血管内科介入手术过程中给予喉罩麻醉的临床效果。方法：选取本院2013年1月-2015年6月期间收治的心血管内科介入手术患儿52例作为研究对象，按照不同麻醉方法分为试验组和对照组，每组各26例，其中试验组行喉罩麻醉，对照组行气管插管麻醉。分别观察两组患儿的血流动力学指标，比较拔管时间及清醒时间和苏醒期不良反应发生情况。结果：试验组患儿在麻醉后的不同时刻（T2、T3、T4时刻）的心率（HR）与平均动脉压（MAP）均明显低于对照组，差异均有统计学意义（P<0.05）。试验组的拔管时间与清醒时间均明显短于对照组，差异均有统计学意义（P<0.01）。试验组苏醒期出现躁动、咽痛、喉痉挛等不良反应的发生率为11.5%，明显低于对照组的38.5%，差异有统计学意义（P<0.05）。结论：心血管内科疾病患者在行介入手术中，采用喉罩麻醉具有良好的效果。与传统气管插管相比，其具有稳定血流动力学、缩短清醒时间、降低苏醒期不良反应发生率等优点，值得临床推广使用。%Objective:To analyze the clinical effect of laryngeal mask in the anesthesia of interventional surgery of cardiovascular internal medicine.Method:52 children with interventional surgery in cardiovascular internal medicine were selected in our hospital from January 2013 to June 2015,and they were divided into the experimental group and the control group according to the different anesthesia methods,26 cases in each group. The experimental group was given laryngeal mask anesthesia,the control group was given tracheal intubation. The hemodynamic indexes, extubation time,waking time and adverse reactions in recovery phase between the two groups were observed and compared.Result:The heart rate(HR),the mean arterial pressure(MAP) of the experimental group at different time after anesthesia(at T2,T3,T4 time) were significantly lower than those of the control group,the differences were statistically significant(P<0.05).The extubation time and waking time of the experimental group were significantly shorter than the control group,the differences were statistically significant (P<0.01).The incidence of adverse reactions(restlessness,sore throat,laryngeal spasm) in the experimental group was 11.5%,which was significantly lower than 38.5% of the control group,the difference was statistically significant(P<0.05).Conclusion:In cardiovascular internal medicine disease patients with interventional operation,using a laryngeal mask for anesthesia has a good effect.Compared with endotracheal intubation,it has the advantages of stabilize hemodynamics,shorten the waking time and reduce the incidence of adverse reactions in the recovery phase,is worthy of clinical popularization and application.